Cargando…

Management of Benign and Malignant Pancreatic Duct Strictures

The diagnosis and management of pancreatic strictures, whether malignant or benign, remain challenging. The last 2 decades have seen dramatic progress in terms of both advanced imaging and endoscopic therapy. While plastic stents remain the cornerstone of the treatment of benign strictures, the adve...

Descripción completa

Detalles Bibliográficos
Autores principales: Dawod, Enad, Kahaleh, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Gastrointestinal Endoscopy 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903078/
https://www.ncbi.nlm.nih.gov/pubmed/28724280
http://dx.doi.org/10.5946/ce.2017.085
_version_ 1783314879961104384
author Dawod, Enad
Kahaleh, Michel
author_facet Dawod, Enad
Kahaleh, Michel
author_sort Dawod, Enad
collection PubMed
description The diagnosis and management of pancreatic strictures, whether malignant or benign, remain challenging. The last 2 decades have seen dramatic progress in terms of both advanced imaging and endoscopic therapy. While plastic stents remain the cornerstone of the treatment of benign strictures, the advent of fully covered metal stents has initiated a new wave of interest in calibrating the pancreatic duct with fewer sessions. In malignant disease, palliation remains the priority and further data are necessary before offering systematic pancreatic stenting.
format Online
Article
Text
id pubmed-5903078
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Korean Society of Gastrointestinal Endoscopy
record_format MEDLINE/PubMed
spelling pubmed-59030782018-05-01 Management of Benign and Malignant Pancreatic Duct Strictures Dawod, Enad Kahaleh, Michel Clin Endosc Review The diagnosis and management of pancreatic strictures, whether malignant or benign, remain challenging. The last 2 decades have seen dramatic progress in terms of both advanced imaging and endoscopic therapy. While plastic stents remain the cornerstone of the treatment of benign strictures, the advent of fully covered metal stents has initiated a new wave of interest in calibrating the pancreatic duct with fewer sessions. In malignant disease, palliation remains the priority and further data are necessary before offering systematic pancreatic stenting. Korean Society of Gastrointestinal Endoscopy 2018-03 2017-07-20 /pmc/articles/PMC5903078/ /pubmed/28724280 http://dx.doi.org/10.5946/ce.2017.085 Text en Copyright © 2018 Korean Society of Gastrointestinal Endoscopy This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Dawod, Enad
Kahaleh, Michel
Management of Benign and Malignant Pancreatic Duct Strictures
title Management of Benign and Malignant Pancreatic Duct Strictures
title_full Management of Benign and Malignant Pancreatic Duct Strictures
title_fullStr Management of Benign and Malignant Pancreatic Duct Strictures
title_full_unstemmed Management of Benign and Malignant Pancreatic Duct Strictures
title_short Management of Benign and Malignant Pancreatic Duct Strictures
title_sort management of benign and malignant pancreatic duct strictures
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903078/
https://www.ncbi.nlm.nih.gov/pubmed/28724280
http://dx.doi.org/10.5946/ce.2017.085
work_keys_str_mv AT dawodenad managementofbenignandmalignantpancreaticductstrictures
AT kahalehmichel managementofbenignandmalignantpancreaticductstrictures